FDC enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
6,131————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
611521536475481
———0.0−0.6
0.00.00.10.30.6
5,520————
−611−521−536−475−481
₹339.02————
2,6692,4852,2812,0971,982
0.0%0.0%0.0%0.0%0.0%
2.41×————
15.08×————
18.06×————
397.40×————
Reference items — trailing FY values
2,2892,1712,1081,9431,784
366346325339251
306287271299212
—200318221155
13.913.922112741.8
—12.622012741.7
—18796.793.4113
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FDC₹376.55

FDC Limited

· Pharma & Health
₹ CrorePeersIOLCPMOREPENLABINNOVACAPORCHPHARMASENORESGUJTHEMRPGLIFESANOFIMcap ₹6,131 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————6,130.6
- Cash, Equiv & ST Investments481.2475.4536.1521.4611.1
+ Minority Interest-0.60.0———
+ Total Debt0.60.30.10.00.0
Enterprise Value————5,519.6
Net Debt (memo)-480.5-475.2-536.0-521.4-611.1
EV per Share————339.02
Total Capital1,982.02,097.42,281.22,485.12,668.9
Total Debt/Total Capital0.030.010.000.000.00
EV/Sales————2.41
EV/EBITDA————15.08
EV/EBIT————18.06
EV/Free Cash Flow————397.40
Reference Items — Trailing FY Values
Sales1,783.81,942.92,108.12,170.92,289.3
EBITDA251.0338.5324.8346.1365.9
EBIT212.0298.6271.1286.9305.7
Operating Cash Flow154.9220.8317.6200.5—
Free Cash Flow41.8127.4220.813.913.9
FCFF (free cash flow to the firm)41.7127.3219.712.6—
Capital Expenditure113.193.496.7186.6—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.